Therefore, more high-quality research and better imaging technologies such as quantitative ultrasound are required to assess whether circulating RBP4 levels were increased in NAFLD patients diagnosed by noninvasive technique. Here, RBP4 is linked to metabolic dysfunction-associated steatotic liver disease.